COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,704 Articles (22,913 medRxiv, 8,791 bioRxiv)

Most recent first Previous |  Page 582: Articles 5811-5820  | Next

An oral vaccine for SARS-CoV-2 RBD mRNA-bovine milk-derived exosomes induces a neutralizing antibody response in vivo
Zhang, Q., Wang, M., Han, C., Wen, Z., Meng, X., Qi, D., Wang, N., Du, H., Wang, J., Lu, L., Ge, X.
10.1101/2022.12.19.517879 — Posted: 2022-12-20
Rapid recall and de novo T cell responses during SARS-CoV-2 breakthrough infection
Koutsakos, M., Reynaldi, A., Lee, W. S., Nguyen, J., Amarasena, T., Taiaroa, G., Kinsella, P., Liew, K. C., Tran, T., Kent, H. E., Tan, H.-X., Rowntree, L. C., Nguyen, T. H. O., Thomas, P., Kedzierska, K., Petersen, J., Rossjohn, J., Williamson, D. A., Khoury, D., Davenport, M. P., Kent, S. J. P., Wheatley, A. K., Juno, J. A.
10.1101/2022.12.19.521129 — Posted: 2022-12-20
Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages
Scarpa, F., Sanna, D., Azzena, I., Casu, M., Cossu, P., Fiori, P. L., Benvenuto, D., Imperia, E., Giovanetti, M., Ceccarelli, G., Cauda, R., Cassone, A., Pascarella, S., Ciccozzi, M.
10.1101/2022.12.20.521197 — Posted: 2022-12-20
Changing social contact patterns among US workers during the COVID-19 pandemic: April 2020 to December 2021
Kiti, M. C., Aguolu, O. G., Zelaya, A., Chen, H., Ahmed, N., Battross, J., Liu, C., Nelson, K., Jenness, S. M., Melegaro, A., Ahmed, F., Malik, F., Omer, S. B., Lopman, B.
10.1101/2022.12.19.22283700 — Posted: 2022-12-20
Different B cell activation patterns in asymptomatic and symptomatic COVID-19 patients
Pham, N., Talih, N., Ehrhart, F., Evelo, C., Kutmon, M.
10.1101/2022.12.19.521064 — Posted: 2022-12-20
Outcomes in Patients with Acute Hypoxemic Respiratory Failure Secondary to COVID-19 Treated with Noninvasive Respiratory Support versus Invasive Mechanical Ventilation
Fisher, J., Subbian, V., Essay, P., Pungitore, S., Bedrick, E., Mosier, J.
10.1101/2022.12.19.22283704 — Posted: 2022-12-20
Humoral responses against BQ.1.1 elicited after breakthrough infection and SARS-CoV-2 mRNA vaccination
Tauzin, A., Benlarbi, M., Medjahed, H., Gregoire, Y., Perreault, J., Gendron-Lepage, G., Gokool, L., Morrisseau, C., Arlotto, P., Tremblay, C., Kaufmann, D. E., Martel-Laferriere, V., Levade, I., Cote, M., De Serres, G., Bazin, R., Finzi, A.
10.1101/2022.12.20.22283723 — Posted: 2022-12-20
Number of COVID-19 hospitalisations averted by vaccination: Estimates for the Netherlands, August 2, 2021 through August 30, 2022
van Iersel, S. C., McDonald, S. A., de Gier, B., Knol, M. J., de Melker, H. E., van Werkhoven, C., The RIVM COVID-19 epidemiology and surveillance team, , Hahne, S. J.
10.1101/2022.12.20.22283713 — Posted: 2022-12-20
The Effect of the COVID-19 Pandemic on Life Expectancy in the US: An Application of Hybrid Life Expectancy
Sanderson, W. C., Scherbov, S.
10.1101/2022.12.19.22283697 — Posted: 2022-12-20
Systematic review: Longitudinal effects of the COVID-19 pandemic on child and adolescent mental health
Wolf, K., Schmitz, J.
10.1101/2022.12.20.22283720 — Posted: 2022-12-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).